Pharmaceuticals stories
XYZ Reality has renewed its ISO 27001 certification, underscoring its commitment to data security in sectors like defence, energy and pharmaceuticals.
Phosphorus Cybersecurity has appointed Sonu Shankar as President and COO following a record quarter driven by demand for automated security across the Internet of Things.
Nebius has awarded over $850,000 in GPU credits to four AI health startups advancing cancer prediction, drug discovery, genomics and diagnostics.
Ransomware attacks on industrial firms surged to 708 in Q1 2025, led by manufacturing, with North America and Europe hardest hit, warns Dragos report.
AI adoption is crucial for businesses to thrive, not just survive, amid fears of job losses; embracing AI boosts productivity and job evolution.
FourKites and Chorus partner to enhance supply chain visibility and inventory management with AI-powered digital twins launching in Q2 2025.
Appian's 2025 Innovation Awards honour Ramsay Health Care and Westpac for pioneering AI and process orchestration to transform services and boost efficiency.
Hurdle uses an AI platform to speed up diagnostics development, tackling inefficiencies and enabling quicker, scalable precision medicine solutions.
Te Aho o Te Kahu is creating a national chemotherapy database to boost ovarian cancer survival rates in New Zealand, following successful Scandinavian models.
Australia's pharmaceutical industry is tackling complex logistics challenges, ensuring temperature-sensitive medications remain effective amid rising demand.
NVIDIA and Google's Alphabet have announced a significant collaboration to enhance AI accessibility in sectors like healthcare and energy, integrating cutting-edge technologies.
AI use in healthcare is booming, with the market set to hit USD $187bn by 2030, but experts warn of risks from data bias, errors, and weak governance frameworks.
Small business failure risk in Australia has risen 4.5%, outpacing 2.9% growth, hitting micro and young firms hardest amid shifting spending and inflation pressures.
Kyorin Pharmaceutical partners with Elix to enhance drug discovery using Elix Discovery, an AI platform aiming to accelerate research and improve R&D outcomes.
AI-powered predictive risk scores are revolutionising disease prevention by enabling early detection and personalised health interventions before symptoms arise.
Elix and LINC launch the world's first AI drug discovery platform using federated learning, enabling pharma firms to collaborate on models without sharing sensitive data.
UK leads Europe in AI investment with 74% of organisations boosting generative AI spending, driving major cost savings and workforce transformation.
Professor Henrik von Scheel, Industry 4.0 originator, will headline Industrial Transformation Australia 2025 in Sydney, discussing future megatrends shaping manufacturing.
Toronto AI firm Skinopathy launches GetSkinHelp app, enabling Canadians to screen for skin cancer from home and access timely medical care.
Pharmx has launched a new supplier portal designed to cut supply chain integration from twelve weeks to just one day, benefiting over 7,000 Australian pharmacies.